跳至主要内容
临床试验/NCT02041546
NCT02041546已完成4 期

Zekai Tahir Burak Maternity Teaching Hospital

Zekai Tahir Burak Women's Health Research and Education Hospital1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2013年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
30
试验地点
1
主要终点
Duration of mechanical ventilation

研究概览

简要总结

Meconium aspiration syndrome (MAS) is an important cause of severe respiratory failure in newborn infants. Treatment for MAS is mainly supportive but surfactant therapy might change the course of the disease. Aim of the study to evaluate whether lung lavage with dilute or bolus poractant alfa changes the duration of mechanical respiratory support or other outcomes in MAS.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
— 至 7 Days(Child)
性别
All
接受健康志愿者

入选标准

  • Infants with a gestational age ≥ 36 weeks, birth weight ≥ 2.0 kg, evidence of passage of meconium at or before delivery, typical chest radiology findings and mechanically ventilated infants with a mean airway pressure ≥ 12 cm H2O were enrolled.

排除标准

  • Congenital cardiac anomalies
  • Major congenital anomalies
  • Hemodynamically unstable infants

研究组 & 干预措施

Bolus surfactant

Active Comparator

Bolus surfactant 100 mg/kg proctant alfa

干预措施: Bolus surfactant (Drug)

Lung lavage with surfactant

Active Comparator

Lung lavage with surfactant

干预措施: Lung lavage with surfactant (Drug)

结局指标

主要结局

Duration of mechanical ventilation

时间窗: up to 2 weeks

Total duration of mechanical ventilation, mode and ventilator parameters are noted till the baby is on mechanical ventilation.

次要结局

  • Complications(up to 4 weeks)
  • Duration of Hospital Stay(Up to 8 weeks or till discharge)
  • Mortality(Up to 3 months or till discharge)

研究者

发起方
Zekai Tahir Burak Women's Health Research and Education Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Mehmet Yekta

Zekai Tahir Burak Maternity and Teaching Hospital

Zekai Tahir Burak Women's Health Research and Education Hospital

研究点 (1)

Loading locations...

相似试验